<scp>S100</scp> calcium‐binding protein beta (S100B) in serum as a biomarker for epilepsy after traumatic brain injury: A register‐based cohort study in Danish adults
Elevated serum S100B levels after TBI were associated with subsequent epilepsy, likely reflecting the extent of intracranial injury. Despite study limitations, these findings support the potential of S100B as a prognostic biomarker.
Authors
- Julie Werenberg Dreier (ORCID: https://orcid.org/0000-0002-9339-4170)
- Kasper Lolk (ORCID: https://orcid.org/0000-0003-2639-7969)
- Jakob Munkholt Christensen (ORCID: https://orcid.org/0000-0002-2495-8905)
- Betina B. Trabjerg (ORCID: https://orcid.org/0000-0001-6282-2614)
- Johan Zelano
Institutions
- Aarhus University (DK)
- Sahlgrenska University Hospital (SE)
- Aarhus University Hospital (DK)
- Wallenberg Wood Science Center (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1002/epi.70049
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00